Inherited and acquired factor v deficiency

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 3, 2011, Pages 160-166

  Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b   Montagnana, Martina ^c   Manzato, Franco ^d   Guidi, Gian C ^c   Franchini, Massimo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF VERONA   (Italy)

^d CARLO POMA HOSPITAL   (Italy)

Author keywords

Bleeding; coagulation; deficiency; factor V; hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ACQUIRED FACTOR V DEFICIENCY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; DISEASE SEVERITY; GENE; GENE MUTATION; HEMOPHILIA A; HUMAN; INHERITED COAGULOPATHY; INHERITED FACTOR V DEFICIENCY; ISOLATED FACTOR V DEFICIENCY; LMAN1 GENE; MCFD2 GENE; PRIORITY JOURNAL; QUEBEC PLATELET DISORDER; REVIEW;

ANIMALS; FACTOR V; FACTOR V DEFICIENCY; HEMOPHILIA A; HEMORRHAGE; HUMANS; MUTATION;

EID: 79955071646     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283424883     Document Type: Review

References (59)

1. Kane WH, Davie EW. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci U S A 1986; 83:6800-6804. (Pubitemid 16002321)
2. Nicolaes GAF, Dahlback B. Factor V and thrombotic disease. Description of a Janus-faced protein. Arterioscler Thromb Vasc Biol 2002; 22:530-538.
3. Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 1987; 26:6508-6514. (Pubitemid 17155516)
4. Duckers C, Simioni P, Rosing J, Castoldi E. Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol 2009; 146:17-26.
5. Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994; 269:18735-18738. (Pubitemid 24226180)
6. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993; 90:1004-1008. (Pubitemid 23053939)
7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67. (Pubitemid 24144355)
8. Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V Cambridge: a new mutation (Arg306Thr) associated with resistance to activated protein C. Blood 1998; 91:1140-1144. (Pubitemid 28086865)
9. Chan WP, Lee CK, Kwong YL, Lam CK, Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 1998; 91:1135-1139. (Pubitemid 28086864)
10. Castaman G, Faioni EM, Tosetto A, Bernardi F. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis. Haematologica 2003; 88:1182-1189. (Pubitemid 37362552)
11. Zehnder JL, Hiraki DD, Jones CD, Gross N, Grumet FC. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost 1999; 82:1097-1099. (Pubitemid 29419725)
12. Peyvandi F, Palla R, Menegatti M, Mannucci PM. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost 2009; 35:349-355.
13. Peyvandi F, Favaloro EJ. Rare bleeding disorders. Semin Thromb Hemost 2009; 35:345-347.
14. Asselta R, Peyvandi F. Factor V deficiency. Semin Thromb Hemost 2009; 35:382-389.
15. Vos HL. An online database of mutations and polymorphisms in and around the coagulation factor V gene. J Thromb Haemost 2007; 5:185-188. (Pubitemid 44921086)
16. Guasch JF, Cannegieter S, Reitsma PH, van't Veer-Korthof ET, Bertina RM. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haemat 1998; 101:32-39. (Pubitemid 28197771)
17. van Wijk R, Nieuwenhuis K, van den Berg M, Huizinga EG, van der Meijden BB, Kraaijenhagen RJ, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood 2001; 98:358-367.
18. Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood 2000; 96:1443-1448. (Pubitemid 30658475)
19. Tanis BC, van der Meer FJ, BloemRM, Vlasveld LT. Successful excision of a pseudotumour in a congenitally factor V deficient patient. Br J Haemat 1998; 100:380-382. (Pubitemid 28131074)
20. van Wijk R, Montefusco MC, Duga S, Asselta R, van Solinge W, Malcovati M, et al. Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency. Br J Haemat 2001; 114:871-874. (Pubitemid 32953746)
21. Ajzner E, Balogh I, Szabo T, Marosi A, Haramura G, Muszbek L. Severe coagulation factor V deficiency caused by 2 novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene. Blood 2002; 99:702-705. (Pubitemid 34533112)
22. Duga S,Montefusco MC, Asselta R, Malcovati M, Peyvandi F, Santagostino E, et al. Arg2074-to-cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. Blood 2003; 101:173-177. (Pubitemid 36025905)
23. Asselta R, Tenchini ML, Duga S. Inherited defects of coagulation factor V: the hemorrhagic side. J Thromb Haemost 2006; 4:26-34.
24. Diamandis M, Veljkovic DK, Maurer-Spurej E, Rivard GE, Hayward CP. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis 2008; 19:109-119. (Pubitemid 351252988)
25. Owren P. Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet 1947; 1:446-448.
26. Huang JN, Koerper MA. Factor V deficiency: a concise review. Haemophilia 2008; 14:1164-1169.
27. Preston FE, Jennings I, Kitchen DP, Woods TA, Kitchen S. Variability in factor V:C assays in UK National External Quality Assessment Scheme surveys: there is a need for an international standard. Blood Coagul Fibrinolysis 2005; 16:529-531. (Pubitemid 41794949)
28. Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency. Semin Thromb Hemost 2009; 35:390-399.
29. Zhang B, Cunningham MA, Nichols WC, Bernat JA, Seligsohn U, Pipe SW, et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet 2003; 34:220-225. (Pubitemid 36666936)
30. Zhang B, Spreafico M, Zheng C, Yang A, Platzer P, Callaghan MU, et al. Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. Blood 2008; 111:5592-5600.
31. World Federation of Hemophilia. What is a bleeding disorder? http:// www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=26&contentid= 5&rptname=bleeding. [Accessed 4 August 2010].
32. Knoble P, Lechner K. Acquired factor V inhibitors. Baillieres Clin Haematol 1998; 11:305-318. (Pubitemid 29103546)
33. Favaloro EJ, Posen J, Ramakrishna R, Soltani S, McRae S, Just S, et al. Factor V inhibitors: rare or not so uncommon? A multilaboratory investigation. Blood Coagul Fibrinolysis 2004; 15:637-647. (Pubitemid 39612969)
34. Miesbach W, Voigt J, Peetz D, Scharrer I. Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin. Med Klin 2003; 98:339-343. (Pubitemid 36806752)
35. Lucia JF, Aguilar C. A case of an asymptomatic idiopathic inhibitor to coagulation factor V. Haemophilia 2005; 11:178-180. (Pubitemid 40468068)
36. Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul Fibrinolysis 2003; 14:87-93. (Pubitemid 36206729)
37. Emori Y, Sakugawa M, Niiya K, Kiguchi T, Kojima K, Takenaka K, et al. Lifethreatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagul Fibrinolysis 2002; 13:555-559.
38. Koyama JA, Saito T, Kusano T, Hirosawa S. Factor V inhibitor associated with Sjogren's syndrome. Br J Haematol 1995; 89:893-896.
39. Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002; 42:18-26.
40. Banninger H, Hardegger T, Tobler A, Barth A, Schüpbach P, Reinhart W, et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993; 85:528-532. (Pubitemid 23349056)
41. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001; 233:88-96. (Pubitemid 32043608)
42. Lu L, Liu Y, Wei J, Zhang L, Yang R. Acquired inhibitor of factor V: first report in China and literature review. Haemophilia 2004; 10:661-664. (Pubitemid 39317776)
43. Leus B, Devreese K, Van den Bossche J, Malfait R. Factor V inhibitor: case report. Blood Coagul Fibrinolysis 2006; 17:585-587. (Pubitemid 44434972)
44. Caers J, Reekmans A, Jochmans K, Naegels S, Mana F, Urbain D, et al. Factor V inhibitor after injection of human thrombin (Tissucol) into a bleeding peptic ulcer. Endoscopy 2003; 35:542-544. (Pubitemid 36705650)
45. Bowman LJ, Anderson CD, Chapman WC. Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost 2010; 36:477-484.
46. Wiwanitkit V. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases. Clin Appl Thromb Hemost 2006; 12:485-488. (Pubitemid 44359247)
47. Morris CJ, Curris N. Acquired factor V inhibitor in a critically ill patient. Anaesthesia 2009; 64:1014-1017.
48. Ang AL, Kuperan P, Ng CH, Ng HJ. Acquired factor V inhibitor. A problembased systematic review. Thromb Haemost 2009; 101:852-859.
49. Ortel T. Clinical and laboratory manifestations of antifactor V antibodies. J Lab Clin Med 1999; 133:326-334. (Pubitemid 29373029)
50. Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al., on behalf of the RCPA QAP in Haematology Haemostasis Committee. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multicentre evaluation. Thromb Haemost 2006; 96:73-78. (Pubitemid 44160873)
51. Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al., on behalf of the RCPA QAP in Haematology Haemostasis Committee. Misidentification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation. Pathology 2007; 39:504-511. (Pubitemid 47454494)
52. Fu YX, Kaufman R, Rudolph AE, Collum SE, Blinder MA. Multimodality therapy of an acquired factor V inhibitor. Am J Hematol 1996; 51:315-318. (Pubitemid 26117545)
53. Franchini M, Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Haemost 2010; 36:485-492.
54. Jansen M, Schmaldienst S, Banyai S, Quehenberger P, Pabinger I, Derfler K, et al. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol 2001; 112:91-97. (Pubitemid 32151155)
55. de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C. Highdose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. Am J Hematol 2003; 74:187-190. (Pubitemid 37363017)
56. Bayani N, Rugina M, Haddad-Vergnes L, Lelong F. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors. Am J Hematol 2002; 71:33-36. (Pubitemid 34988583)
57. Lebrun A, Leroy-Matheron C, Arlet JB, Bartolucci P, Michel M. Successful treatment with rituximab in a patient with an acquired factor V inhibitor. Am J Hematol 2008; 83:163-164.
58. Lian EC, Tzakis AG, Andrews D. Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. Am J Hematol 2004; 77:363-365. (Pubitemid 39578317)
59. Cao L, Wang Z, Li H, Wang W, Zhao X, Zhang W, Ding J, Ruan C. Gene analysis and prenatal diagnosis for two families of congenital factor V deficiency. Haemophilia 2010. [Epub ahead of print]